The Future of Real-World Evidence: U.S. Market Insights and Projections to 2033
The U.S. Real World Evidence Solutions Market Size is Anticipated to Exceed USD 20.32 Billion by 2033, Growing at a CAGR of 12.37% from 2023 to 2033. Real-world evidence (RWE), defined by the U.S. FDA as clinical evidence derived from real-world data (RWD), is becoming increasingly influential in the decision-making process throughout the product life […]